Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors

Summary

Curavit Clinical Research has acquired CRO assets from Lindus Health to expand its clinical research capabilities and deliver unified U.S. and European trial services. The combined operations aim to accelerate trial execution and recruitment for life science sponsors across multiple therapeutic areas.